Breast cancer is the leading factor of mortality among women globally. According to the World Health Organization (2015), breast cancer is the second most common cancer after lung cancer; and contributes to nearly 15% of all cancer death among women in 2015. Moringa oleifera (M. oleifera) is a highly nutritious vegetable with various therapeutic benefits including anticancer. The therapeutic benefits are attributed to its bioactive compounds. Thus, study on the bioactive compounds of M. oleifera using various extraction methods with different extracting solvents have been the main focus of many researchers. Methods: The current study was carried out using Ultrasound Assisted Sequential Extraction (UASE) method and three extracting solvents (99.7% ethanol, 50% ethanol and deionised water) with ascending polarity. The yielded extracts were tested for possible anticancer effects against human breast adenocarcinoma cell line, MCF-7 and non-tumorigenic cell line, MCF-10A using microtitrate tetrazolium (MTT) assay. Results: The IC50 values of the 99.7% ethanol, 50% ethanol and deionised water extracts were 25, 200 and 180 μg/mL, respectively. Conclusion: M. oleifera could be a potential preventative and/or therapeutic agent for breast cancer, either used alone or as an adjunct to the standard chemotherapeutic drugs.